India's pharmaceutical exports rose 3% to $8.04 billion in Q2 2027-28, driven by strong demand in European markets, ...
In response to safety issues surrounding cough syrups in India, the CDSCO mandates strict monitoring of high-risk solvents ...
Explore groundbreaking research on biological aging, discover how cellular functions can be reprogrammed, and learn practical ...
Piramal Pharma reduces reliance on Chinese raw materials to single-digit levels to enhance supply-chain resilience amid geopolitical tensions. Chairperson Nandini Piramal discusses the company's ...
Eli Lilly, known for its blockbuster weight-loss and anti-diabetes drugs, is now focusing on neurosciences, with significant ...
Discover how India is addressing cancer drug affordability with a new pricing strategy that aims to lower costs for patients ...
Despite beating quarterly sales and profit expectations, GSK's stock fell due to concerns over its drug pipeline and weak ...
Eli Lilly has announced that its experimental obesity drug, retatrutide, has outperformed Novo's Ozempic in a Phase 3 trial, ...
The Indian Patent Office has rejected a patent application for the BPaL regimen, a groundbreaking treatment for ...
Sandoz, the Swiss generic drugmaker, adjusts its sales growth forecast to 5-6% due to supply constraints, impacting investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results